As of this week we have completed over 1,500 ChIP-Seq samples on the Helicos. A few nanograms, no library creation, just a little poly A tailing and zoom, 9-14 million reads on 46 samples every 14 days (we like to relax before we fill it up again.).
Just don't ask me why they just got delisted on NASDAQ and are trading at 22 cents. I have no idea. ;-( Keith Robison spells it out pretty well in the other thread. Their marketing should have been something like "It's all about the message" and focused on ChIP-Seq, RNA-Seq, DGE and all of the above from paraffin, nanogram amounts, no amplification, no bias.
They should have never chased after the human genome. Wrong tool for the job.
-Paul Morrison
-
Dana Farber has a Helicos. Contact Paul Morrison there.
Leave a comment:
-
Does anyone have any experience with Helicos sequencing
Hello Everyone,
I was wondering if anyone has any experience in Helicos sequencing. I saw the technology on its website, and it looked pretty robust. I was wondering what were its pros and cons compared to SoliD and Illumina and it was something one would want to invest in.
Thanks
Abhijit
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Leave a comment: